Loading...
 
Translate Register Log In Login with facebookLogin and Register

Vitamin D should be an almost universal feature of the care of young adults with sickle cell disease – May 2018

Risk factors for vitamin D deficiency in sickle cell disease.

Br J Haematol. 2018 May 16. doi: 10.1111/bjh.15270. [Epub ahead of print]

VitaminDWiki

The title of this page is condensed from conclusion below


Han J1,2,3, Zhang X2, Saraf SL2, Gowhari M2, Molokie RE2,4, Hassan J2, Jain S2, Shah BN2, Abbasi T2, Machado RF5, Gordeuk VR2.
1 Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, IL, USA.
2 Department of Medicine, Hematology/Oncology, University of Illinois at Chicago, Chicago, IL, USA.
3 Center for Pharmacoepidemiology and Pharmacoeconomic Research, University of Illinois at Chicago, Chicago, IL, USA.
4 Jesse Brown VA Medical Center, Chicago, IL, USA.
5 Division of Pulmonary, Critical Care, Sleep, and Occupational Medicine, Indiana University Department of Medicine, Indianapolis, IN, USA.

Vitamin D deficiency (VDD), 25-OHD levels <20 ng/ml, is prevalent among patients with sickle cell disease (SCD) and is linked to acute and chronic pain and bone fracture in this population. There is limited literature regarding VDD-associated risk factors for SCD.
We examined potential clinical and genomic parameters associated with VDD in 335 adults with SCD in a cross-sectional study. VDD was present in 65% of adult SCD patients, and 25-OHD levels independently and positively correlated with older age (P < 0·001) and vitamin D supplementation (P < 0·001). 25-OHD levels were higher in SCD patients over 40 years of age compared to the general African-American population.
Both lower 25-OHD levels and increased pain frequency were associated with increased expression of SLC6A5 encoding glycine transporter-2 (GlyT2), a protein involved in neuronal pain pathways. Lower 25-OHD levels were also associated with increased expression of CYP3A4, and with decreased expression of GC (also termed DBP) and VDR, three genes involved in vitamin D metabolism.
We conclude that vitamin D supplementation should be an almost universal feature of the care of young adults with SCD, and that further research is warranted into genomic factors that regulate vitamin D metabolism in SCD.

PMID: 29767851 DOI: 10.1111/bjh.15270

Created by admin. Last Modification: Sunday May 20, 2018 20:09:03 GMT-0000 by admin. (Version 2)
See any problem with this page? Report it (FINALLY WORKS)